RA Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,365,912
Closed -$13.5M 49
2019
Q4
$13.5M Hold
2,365,912
0.41% 31
2019
Q3
$8.46M Buy
+2,365,912
New +$9.17M 0.5% 26
2015
Q3
Sell
-766,000
Closed -$17.9M 55
2015
Q2
$17.9M Sell
766,000
-1,834,000
-71% -$39.9M 1.81% 19
2015
Q1
$58.3M Buy
+2,600,000
New +$49.8M 5.79% 7
2014
Q4
Sell
-1,217,900
Closed -$17.4M 53
2014
Q3
$17.4M Sell
1,217,900
-185,759
-13% -$2.68M 2.06% 15
2014
Q2
$22.5M Sell
1,403,659
-384,736
-22% -$5.8M 2.27% 13
2014
Q1
$32.3M Hold
1,788,395
2.32% 15
2013
Q4
$35.1M Buy
1,788,395
+1,188,395
+198% +$17.4M 4.08% 9
2013
Q3
$7.14M Hold
600,000
0.75% 29
2013
Q2
$6.6M Buy
+600,000
New +$12.6M 0.88% 23

Other funds holding DVAX

RA Capital Management's DVAX Position: Q1 2020 in Review

RA Capital Management sold out of Dynavax Technologies (DVAX) in Q1 2020, closing a stake of 2,365,912 shares — an estimated $13.5M sold.

RA Capital Management first reported a position in DVAX in Q2 2013 and held it in 10 quarters. The position peaked at $58.3M in Q1 2015. 113 funds tracked by Wall St. Rank hold DVAX as of Q1 2020.

  • RA Capital Management reported no remaining Dynavax Technologies position as of Q1 2020 after selling out during the quarter.
  • RA Capital Management sold 2,365,912 Dynavax Technologies shares in Q1 2020, an estimated $13.5M.
  • RA Capital Management first reported a position in Dynavax Technologies in Q2 2013 and held it in 10 quarters.
  • RA Capital Management's Dynavax Technologies position peaked at $58.3M in Q1 2015.
  • 113 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2020.

Based on RA Capital Management's 13F filing for Q1 2020, filed 15 May 2020.